- An early evaluation from the continued RESTORE trial suggests semaglutide could enhance fertility-related outcomes in females with polyendocrine metabolic ovarian syndrome (PMOS), previously often known as PCOS.
- A assessment additionally means that GLP-1 medicine could assist male reproductive well being in these with weight problems by bettering testosterone ranges, reproductive hormones, and sperm high quality whereas additionally bettering metabolic well being.
- The findings assist the concept treating weight problems and metabolic dysfunction with GLP-1 medicine might assist restore hormonal stability and reproductive operate in each men and women. Nonetheless, bigger, longer-term research are needed to verify these results.
Thus, lifestyle changes, comparable to adopting balanced dietary plans, partaking in common bodily exercise, and sustaining a wholesome weight, may also help improve reproductive outcomes and assist fertility.
Now, rising analysis suggests these medicines may have optimistic results on reproductive well being. Two research point out that GLP-1 medicine could supply reproductive advantages, along with supporting weight reduction and metabolic well being.
Firstly, an evaluation revealed in Fertility and Sterility discovered potential enhancements in fertility-related outcomes amongst girls with PMOS.
Secondly, a review of clinical trials offered at ENDO 2026 — which is but to look in a peer-reviewed journal — discovered that GLP-1 medicine could enhance testosterone ranges and sperm high quality in some males with weight problems.
Whereas the findings add to rising curiosity within the relationship between metabolic well being, weight administration, and reproductive operate, the research authors advise warning and word that additional analysis is critical to research this affiliation.
In a proof-of-concept research, researchers from the College of Colorado Anschutz Medical Campus evaluated a subset of members enrolled within the ongoing RESTORE scientific trial.
The RESTORE study is investigating whether or not semaglutide or metformin may also help restore ovulation and enhance reproductive well being in adolescents and adults with PMOS and weight problems.
PMOS is a standard endocrine and metabolic situation
“Raised physique mass index (BMI) reduces fertility by inflicting hormonal imbalances, which may disrupt ovulation in girls,” Clare Thompson, MBBS, BSc, nMRCGP, Common Practitioner on the Cadogan Clinic, the place she leads the Weight Administration Service, who was not concerned within the research, defined to Medical Information Immediately.
“Extra fatty tissue produces oestrogen, which modifications the pure hormone stability required for normal menstrual cycles and egg launch. The next BMI may also alter the fluid surrounding growing eggs, affecting their high quality and talent to be fertilised by sperm,” Thompson defined.
“Lastly, the next BMI modifications the uterine lining which may make it more durable for an embryo to connect and subsequently will increase the chance of miscarriage,” she added.
“GLP-1 medicines may also help a affected person to shed extra pounds safely which may kick begin their fertility by regulating the hormone stability once more which can trigger common ovulation to happen, leading to an elevated probability of being pregnant,” Thompson noetd.
Nonetheless, “there are lots of different causes a feminine could also be obese aside from easy life-style selections, comparable to PMOS, which primarily reduces fertility by disrupting ovulation,” she additional defined.
“It describes a state of affairs the place the hormone imbalance causes a relative rise in androgens (male hormones) alongside insulin resistance, which stalls egg improvement. With out common ovulation it turns into troublesome to conceive and predict when a girl’s fertile window is for replica. Some PMOS sufferers additionally expertise decrease egg high quality and viability and even points with their uterine lining, which may make implantation more durable.”
– Clare Thompson, MBBS, BSc, nMRCGP
The evaluation centered on members ages 12 to 35 years who achieved at the very least 10% weight reduction whereas receiving injectable semaglutide.
Investigators reported that enhancements in reproductive markers appeared sooner than anticipated, prompting the publication of preliminary findings earlier than completion of the bigger research.
In line with the researchers, the findings recommend that semaglutide might probably handle each elements of the situation concurrently, by bettering metabolic well being whereas additionally supporting reproductive operate.
Nonetheless, the research authors emphasised that the present evaluation is preliminary and concerned solely a subset of members. The RESTORE trial is ongoing, and longer-term information will probably be needed to find out whether or not the noticed reproductive advantages are sustained.
“The researchers concluded that substantial weight reduction throughout semaglutide therapy was linked to appreciable enhancements in reproductive well being amongst girls with PMOS and weight problems,” Thompson highlighted.
“The outcomes recommend that addressing extra weight and the underlying metabolic dysfunction related to PMOS may also help restore hormonal stability and enhance reproductive operate. The findings ship early proof that semaglutide could supply a twin profit, concentrating on weight problems and key reproductive challenges related to the situation, together with irregular menstruation and impaired fertility.”
– Clare Thompson, MBBS, BSc, nMRCGP
Individually, a assessment of 5 randomized managed trials offered at ENDO 2026 discovered that GLP-1 medicine, comparable to semaglutide and liraglutide, don’t seem to hurt male fertility and should even enhance testosterone ranges and sperm high quality in some males with weight problems.
“The connection between weight problems, metabolic well being, and fertility has been properly established for a few years,” Philip Werthman, MD, board-certified urologist, males’s well being specialist, and director of the Heart for Male Reproductive Drugs and Vasectomy Reversal in Los Angeles, CA, who was not concerned within the research, informed MNT.
“In each women and men, weight problems can disrupt regular reproductive hormone signaling, impair fertility, and negatively have an effect on reproductive outcomes. In males, we generally see decrease testosterone ranges, practical hypogonadism, erectile dysfunction, and poorer semen parameters,” Werthman defined.
Researchers from the College Hospitals Coventry and Warwickshire and Warwick Medical College in the UK carried out a assessment of trials inspecting GLP-1 medicines in males ages 18 to 65 years, evaluating GLP-1 therapies with placebo or different remedies.
Throughout the research, GLP-1 medicine confirmed no proof of negatively affecting testosterone ranges, reproductive hormones, sexual operate, or sperm high quality.
Notably, a 24-week semaglutide trial reported enhancements in sperm morphology and levels of cholesterol whereas sustaining secure hormone ranges. One other 16-week research discovered that liraglutide elevated testosterone and associated reproductive hormones in males with obesity-related low testosterone.
The researchers word that well being outcomes in these males have been superior to these achieved by means of testosterone substitute remedy alone.
This means a possible shift from testosterone substitute in males with weight problems and low testosterone, as a substitute treating extra weight and metabolic well being, which can restore hormone ranges and protect fertility.
“The male fertility information are additionally turning into more and more compelling,” Werthman added. “Weight problems-related hypogonadism is without doubt one of the commonest reversible causes of low testosterone that I see in follow. A number of research have demonstrated enhancements in testosterone ranges and sure semen parameters following therapy with GLP-1 receptor agonists.”
“Stories involving liraglutide have proven enhancements in sperm focus, motility, morphology, and testosterone ranges. Newer semaglutide information recommend enhancements in sperm morphology and testosterone whereas preserving regular gonadotropin signaling.”
– Philip Werthman, MD
“Probably the most vital scientific distinctions is that GLP-1 therapies seem essentially completely different from testosterone substitute remedy for males who want to protect fertility,” he famous.
“Exogenous testosterone can suppress sperm manufacturing by shutting down the hypothalamic-pituitary-gonadal axis. In distinction, GLP-1 receptor agonists enhance metabolic well being and should enhance endogenous testosterone manufacturing with out impairing spermatogenesis,” Werthman defined.
Whereas the precise mechanism just isn’t absolutely understood, researchers recommend the reproductive advantages from GLP-1 medicine could also be pushed by enhancements in metabolic well being.
Weight problems is understood to have an effect on hormone regulation, ovulation, sperm manufacturing, and total reproductive operate. Weight reduction may also help restore hormonal stability and enhance fertility outcomes in each women and men.
GLP-1 medicine can enhance blood sugar regulation, scale back urge for food, and infrequently produce substantial weight reduction. These metabolic enhancements could not directly assist reproductive well being by decreasing irritation, bettering insulin sensitivity, and restoring hormone manufacturing.
In these with PMOS, insulin resistance is a major contributor to hormonal imbalances and ovulatory dysfunction. Addressing these underlying metabolic issues could assist restore common ovulation and enhance fertility.
“The proof means that weight reduction is the first driver of the reproductive enhancements seen with semaglutide, as substantial weight discount is understood to enhance hormone stability, ovarian operate and fertility in girls with PMOS.”
– Clare Thompson, MBBS, BSc, nMRCGP
“Nonetheless, GLP-1 medicine may have direct results on reproductive well being by way of mechanisms comparable to insulin signalling and ovarian operate. Additional research are wanted to find out how a lot of the profit comes from weight reduction versus the remedy itself,” Thompson famous.
Equally, obesity-related low testosterone is often linked to metabolic dysfunction relatively than major testicular illness. Which means weight discount could assist restore pure hormone manufacturing.
“As a male fertility specialist, I view these findings as extremely encouraging,” Werthman emphasised. “The broader advantages of GLP-1 remedy—together with enhancements in physique composition, insulin resistance, cardiovascular threat components, sleep apnea, and total metabolic well being—can all positively affect reproductive operate.”
“As a result of infertility, weight problems, metabolic syndrome, and low testosterone incessantly coexist, treating the underlying metabolic illness could have substantial downstream reproductive advantages. General, I imagine a lot of the fertility advantages noticed with GLP-1 therapies are at the moment greatest defined by weight reduction and metabolic enchancment,” he informed us.
“Nonetheless, the consistency of rising information in each women and men raises the chance that these medicines could in the end show to have direct reproductive results as properly. Bigger potential research particularly designed to judge fertility outcomes will probably be wanted to reply that query definitively,” Werthman added.
Regardless of the encouraging findings, each analysis groups emphasize that the proof stays preliminary.
The semaglutide research in females represents an early proof-of-concept evaluation from the RESTORE scientific trial, whereas the male fertility findings have been primarily based on a comparatively small variety of research with various methodologies.
Whereas the findings are promising, neither semaglutide nor different GLP-1 receptor agonists have been permitted particularly as fertility remedies.
Future research could look at whether or not these reproductive enhancements translate into greater being pregnant charges, improved stay start outcomes, and long-term reproductive advantages.
For now, the findings present early proof that the fertility dialog surrounding GLP-1 medicines could also be extra nuanced than beforehand thought.
:max_bytes(150000):strip_icc()/GettyImages-2176694300-ae8ac7922e1542e587df999d107f912d.jpg "What Happens to Your Sleep When You Take Magnesium and Melatonin Together?")